1. Home
  2. VSME vs APVO Comparison

VSME vs APVO Comparison

Compare VSME & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSME
  • APVO
  • Stock Information
  • Founded
  • VSME 2013
  • APVO 2016
  • Country
  • VSME Hong Kong
  • APVO United States
  • Employees
  • VSME N/A
  • APVO N/A
  • Industry
  • VSME
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSME
  • APVO Health Care
  • Exchange
  • VSME Nasdaq
  • APVO Nasdaq
  • Market Cap
  • VSME 4.2M
  • APVO 3.7M
  • IPO Year
  • VSME 2023
  • APVO N/A
  • Fundamental
  • Price
  • VSME $1.16
  • APVO $0.21
  • Analyst Decision
  • VSME
  • APVO Strong Buy
  • Analyst Count
  • VSME 0
  • APVO 1
  • Target Price
  • VSME N/A
  • APVO $8.00
  • AVG Volume (30 Days)
  • VSME 476.4K
  • APVO 17.5M
  • Earning Date
  • VSME 11-26-2024
  • APVO 11-07-2024
  • Dividend Yield
  • VSME N/A
  • APVO N/A
  • EPS Growth
  • VSME N/A
  • APVO N/A
  • EPS
  • VSME N/A
  • APVO N/A
  • Revenue
  • VSME $7,991,103.00
  • APVO N/A
  • Revenue This Year
  • VSME N/A
  • APVO N/A
  • Revenue Next Year
  • VSME N/A
  • APVO N/A
  • P/E Ratio
  • VSME N/A
  • APVO N/A
  • Revenue Growth
  • VSME N/A
  • APVO N/A
  • 52 Week Low
  • VSME $0.65
  • APVO $0.14
  • 52 Week High
  • VSME $6.26
  • APVO $10.80
  • Technical
  • Relative Strength Index (RSI)
  • VSME 44.45
  • APVO 43.68
  • Support Level
  • VSME $1.10
  • APVO $0.24
  • Resistance Level
  • VSME $1.62
  • APVO $0.33
  • Average True Range (ATR)
  • VSME 0.21
  • APVO 0.04
  • MACD
  • VSME -0.05
  • APVO -0.01
  • Stochastic Oscillator
  • VSME 23.33
  • APVO 0.70

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a global network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fanbases on social media platforms. The company's business provides value to two major business stakeholders: Creators and Brands. Its Value to Creators: It empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content. Its Value to Brands: the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content strategy and budget and recommending specific Creators.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: